Harvard Medical School's finances are in a precarious place as it prepares for impending layoffs and sweeping cuts.

The country’s premier medical school has lost money for years and leans heavily on research dollars that are now under threat from the White House.

Does the world’s richest university have enough money to survive a battle with the most powerful man in the world? Alan Blinder, a national correspondent for The New York Times who covers education, describes Harvard’s resources and the scientific and medical research at stake.